Cargando…
Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world (it affects 30% of the general adult population). The NAFLD encompasses a histological spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), defined by steatosis, hepatocel...
Autores principales: | Durazzo, Marilena, Belci, Paola, Collo, Alessandro, Grisoglio, Enrica, Bo, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502854/ https://www.ncbi.nlm.nih.gov/pubmed/23209914 http://dx.doi.org/10.1155/2012/464706 |
Ejemplares similares
-
OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
por: Paschetta, Elena, et al.
Publicado: (2015) -
Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
por: Huang, Yue Ye, et al.
Publicado: (2013) -
The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies
por: Meroni, Marica, et al.
Publicado: (2019) -
Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions
por: Notarnicola, Maria, et al.
Publicado: (2021) -
Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
por: Fon Tacer, Klementina, et al.
Publicado: (2011)